Cell Line Development Serum Market Size and Growth 2031

The Cell Line Development Serum Market size was estimated to be US$ 1.16 billion in 2023 and is expected to reach US$ 2.00 billion by 2031; it is estimated to record a CAGR of 7.0% till 2031. Adoption of novel technologies for cell line development is likely to remain key Cell Line Development Serum Market trends.

Cell Line Development Serum Market Analysis

Advancements in drug development, government initiatives for vaccine development, increasing R&D activities in biotechnology and pharmaceutical companies, increasing demand for personalized medicine, and increasing demand for biopharmaceuticals is fuelling the growth of the viral antigen market. Increasing prevalence of chronic and infectious diseases globally requiring novel therapeutics is also driving the growth of the cell line development serum market

Cell Line Development Serum Market Overview

The cell line is a type of established cell culture, wherein the cells multiply in growing medium and in place which has space for growth. Different cell lines are made from other cells. The cell line development serum market growth is mainly attributed to the serum as a source of growth and adhesion factors, hormones, lipids, and minerals for cells' culture in basal media. The serum also regulates cell membrane permeability and serves as a carrier for enzymes, lipids, micronutrients, and trace elements into the cell. Quality and safety are critical considerations in the cell line development serum market, as the use of contaminated or low-quality serum can impact the cell culture performance and product quality.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Cell Line Development Serum Market: Strategic Insights

Cell Line Development Serum Market

• 
  CAGR (2023 - 2031)

  7.0%
• Market Size 2022
  US$ 1.16 Billion
• Market Size 2031
  US$ 2.00 Billion

Market Dynamics

GROWTH DRIVERS

• Increased Vaccine Development
• Rising R&D Investments and Collaborations Among Pharmaceutical and Biotechnology Companies

FUTURE TRENDS

• XXXXXXX
• XXXXXXX
• XXXXXXX

OPPORTUNITIES

• Increasing Awareness about Regenerative Medicine

Key Players

• Thermo Fisher Scientific Inc
• MERCK KGaA
• Cytiva Danaher
• GE Healthcare
• Lonza Group
• HiMedia Laboratories
• Sartorius
• PAN Biotech
• Corning Incorporated
• European Collection of Cell Cultures ECACC

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Type

• Fetal Bovine Serum
• Adult Bovine Serum
• Porcine Serum
• Horse Serum
• Other Animal Serum

Application

• Bioproduction
• Drug Discovery
• Tissue Engineering and Regenerative Medicines
• Toxicity Testing
• Academic Research

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Cell Line Development Serum Market Drivers and Opportunities

Increasing Vaccine Production

Increasing prevalence of chronic conditions as well as infectious diseases is leveraging the demand for vaccine production worldwide. As cell line development plays a crucial role in vaccine development and process of drug discovery, the market is estimated to witness significant growth during the forecast period. Major pharmaceutical and biotechnology players are currently focusing on the establishment of an advanced research facilities to boost the process of vaccine development. Increasing use of cell line for effect of vaccine is fuelling the demand for cell line development which in turn fuels the growth of the cell line development serum market.

Increasing Awareness about Regenerative Medicine – An Opportunity of Cell Line Development Serum Market

Over the last few years, the tissue engineering industry has emerged notably, and it has evolved into the broader spectrum of regenerative medicine. Regenerative medicine focuses on the development of clinical therapies for the repair, maintenance, replacement, and enhancement of biological function, with the use of cell engineering. Cell line development is a crucial and invariable part of regenerative medicine. The stem cells play a crucial role in regenerative medicine research revolves around the use of various types of stem cells such as adult, embryonic, induced pluripotent cells. Cell lines are used in testing and development of drugs, cell-based therapy, and research related to cancer tissues. New regenerative medicine developed in pharmaceutical companies are safely and effectively tested on stem cells to check the potential of the drugs developed and their level of toxicity. Thus, advancements in the regenerative medicine is anticipated to boost the demand for serum used in cell line development.

Cell Line Development Serum Market Report Segmentation Analysis

Key segments that contributed to the derivation of the Cell Line Development Serum Market analysis are type and application.

• Based on type, the Cell Line Development Serum Market is segmented fetal bovine serum, adult bovine serum, porcine serum, horse serum, and others. The fetal bovine serum segment held the largest market share in 2023.
• By application, the market is segmented into bioproduction, drug discovery, tissue engineering and regenerative medicine, toxicity testing, and academic research. The bioproduction segment held the largest share of the market in 2023.

Cell Line Development Serum Market Share Analysis by Geography

The geographic scope of the Cell Line Development Serum Market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

North America has dominated the Cell Line Development Serum Market. In North America, the US holds the significant share of the cell line development serum market. The growth in North America is characterized by an increase in the production for innovative products from pharmaceutical and biotechnology companies, the presence of key market players in the region, and extensive R&D conducted by academic and research institutes. Moreover, increasing focus on advanced method incorporation in development of precision medicine and massive funds from government and other organizations for genomic research  has further stimulated the growth of the cell line development serum market in North America.

Cell Line Development Serum Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Cell Line Development Serum Market News and Recent Developments

The Cell Line Development Serum Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for viral antigens and strategies:

• BioIVT launched human AB serum product line to supplement cell culture media and facilitate cell and gene therapy development. BioIVT is offering both plasma-derived and off-the-clot serum collected from healthy, male AB blood type donors. All products are sterile, filtered, and ready for cell culture. (Source: BioIVT, Company Website, 2021)
• In Feb 2024, Gemini Bioproducts LLC launched a new human AB serum product, GemCellTM Plus Xeno Free, for the cell therapy and regenerative medicine markets. (Source: Biospace, Press Release, 2024)

Cell Line Development Serum Market Report Coverage and Deliverables

The “Cell Line Development Serum Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Market dynamics such as drivers, restraints, and key opportunities
• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis
• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
• Detailed company profiles